JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal

BSE362.1527.1 (+8.09 %)

PREV CLOSE ( ) 335.05

OPEN PRICE ( ) 335.30

BID PRICE (QTY) 363.60 (12)

OFFER PRICE (QTY) 364.75 (8)

VOLUME 24727

TODAY'S LOW / HIGH ( )335.30 381.40

52 WK LOW / HIGH ( )146.6 420.2

NSE362.3527.75 (+8.29 %)

PREV CLOSE( ) 334.60

OPEN PRICE ( ) 331.00

BID PRICE (QTY) 362.00 (96)

OFFER PRICE (QTY) 362.35 (11)

VOLUME 371729

TODAY'S LOW / HIGH( ) 331.00 380.95

52 WK LOW / HIGH ( )145.8 418.9

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1978

Management Info

Rajpal Singh - Chairman Manish Gupta - Managing Director

Registered Office

Address T 210 J,Shabpur Jat, ,
New Delhi,
Delhi-110049

Phone 011-46181100 / 46109900

Email cs@jagsonpal.com

Website www.jagsonpal.com

Registrars Details

MCS Ltd

F-65, ,Okhla Industrial Area,Phase - I,New Delhi

Listing : BSE, NSE, MCX

NEWS

19Sep Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that the Nomination and Remunerat..

20Jul Jagsonpal Pharmaceuticals informs abou
In Compliance with Regulation 74 (5) of SEBI (Depositories and Participa..

16Jul Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that the Board of Directors at th..

31May Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that Centrum Capital (Manager to..

04May Jagsonpal Pharmaceuticals informs abou
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions

	QTR Sep 22	ANNUAL 22
Net Profit	104.11	195.88
Gross Profit	137.92	273.2
Operating Profit	140.22	291.31
Net Sales	605.26	2260.97

EVENT CALENDAR

peer group

Abbott India (BSE) 20259.10 (1.00%)	M.Cap ( in Cr)42771.45
Fredun Pharma (BSE) 1398.95 (3.54%)	M.Cap ( in Cr)628.91
Sanofi India (BSE) 5751.00 (0.64%)	M.Cap ( in Cr)13174.55
Samrat Pharmachem (BSE) 785.00 (4.59%)	M.Cap ( in Cr)240.38
Procter&Gamble Healt (BSE) 4134.15 (0.50%)	M.Cap ( in Cr)6823.51

	PROMOTERS	68.72%
	NON-INSTITUTION	30.85%
	FII	0.13%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%

Scheme Name	Hold(%)
Motilal Oswal S&P B...	0.04

About Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd. was incorporated in the year 1978. Its today's share price is 362.15. Its current market capitalisation stands at Rs 956.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2260.97 Cr and Total Income of Rs.2294.33 Cr. The company's management includes Rajpal Singh, Nandita Singh, Prithipal Singh Kochhar, Pallavi Dinodia Gupta, Radhika Madhukar Dudhat, Debasis Bikash Nandy, Harsha Raghavan, Manish Gupta.

It is listed on the BSE with a BSE Code of 507789 , NSE with an NSE Symbol of JAGSNPHARM and ISIN of INE048B01027. It's Registered office is at T 210 J,Shabpur Jat, New Delhi-110049, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are HL Bansal & Co, PP Thukral & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont's

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities FY-2020-2021 FY-2021-2022 Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote